Psychosis News and Research RSS Feed - Psychosis News and Research

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''
Use of antipsychotic drugs more common in boys than girls, research shows

Use of antipsychotic drugs more common in boys than girls, research shows

Boys are more likely than girls to receive a prescription for antipsychotic medication regardless of age, researchers have found. [More]
FAU awarded $2.1 million to examine effectiveness of antipsychotic medication for schizophrenia

FAU awarded $2.1 million to examine effectiveness of antipsychotic medication for schizophrenia

Florida Atlantic University's Charles E. Schmidt College of Medicine was recently awarded a $2.1 million, two-year contract by Otsuka America Pharmaceutical Inc. to conduct a study to examine the effectiveness of an injectable long-acting antipsychotic medication for schizophrenia and its impact on 30-day hospital readmission rates. [More]
Health Canada informs Canadians that eight unauthorized health products were seized from Better Bodies Supplements

Health Canada informs Canadians that eight unauthorized health products were seized from Better Bodies Supplements

Health Canada is informing Canadians that eight unauthorized health products (listed in the table below) were seized from Better Bodies Supplements, 118 Main Street North, in Airdrie, Alta. [More]
New depression treatment from Magstim to be exhibited at Royal College of Psychiatry International Congress 2015

New depression treatment from Magstim to be exhibited at Royal College of Psychiatry International Congress 2015

The Magstim Company Ltd, an innovative and award winning Wales-based medical device manufacturer, will be showing its Magstim Rapid2 Therapy System at the Royal College of Psychiatry International Congress 2015 in Birmingham, UK, 29th June-2nd July. [More]
Scientists make breakthrough in schizophrenia research

Scientists make breakthrough in schizophrenia research

An international team of scientists led by Cardiff University researchers has provided the strongest evidence yet of what causes schizophrenia - a condition that affects around 1% of the global population. [More]
Childhood trauma increases vulnerability to different health problems in later life

Childhood trauma increases vulnerability to different health problems in later life

Long-term changes in immune function caused by childhood trauma could explain increased vulnerability to a range of health problems in later life, according to new research by the Institute of Psychiatry, Psychology & Neuroscience at King's College London and the NIHR Maudsley BRC. [More]
Hallucinations, delusions more frequent in general population

Hallucinations, delusions more frequent in general population

Hallucinations and delusions in the general population are more common than previously thought. An international study led by The University of Queensland and Harvard Medical School found that hearing voices and seeing things others cannot impacts about five per cent of the general population at some point in their lives. [More]
Researchers find way to prevent, reduce or delay cannabis use amongst at-risk youth

Researchers find way to prevent, reduce or delay cannabis use amongst at-risk youth

Responding to rapidly shifting legal and cultural environments, researchers at the University of Montreal and CHU Sainte-Justine Children's Hospital have found a way to prevent, reduce or delay cannabis use amongst some at-risk youth. Cannabis users are at risk of neurocognitive deficits, reduced educational and occupational attainment, motor vehicle accidents, exacerbation of psychiatric symptoms, and precipitation of psychosis. [More]
Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015. [More]
HQO report shows variations across Ontario's long-term care homes regarding antipsychotic drug use

HQO report shows variations across Ontario's long-term care homes regarding antipsychotic drug use

There are major differences across Ontario's long-term care homes in the percentage of residents who are being prescribed antipsychotic medications, according to Looking for Balance, a report from Health Quality Ontario, the provincial advisor on health care quality. [More]
New UCLA study finds Naltrexone drug as promising treatment for methamphetamine addiction

New UCLA study finds Naltrexone drug as promising treatment for methamphetamine addiction

A new study by UCLA researchers has found that Naltrexone, a drug used to treat alcoholism, may also be a promising treatment for addiction to methamphetamine. [More]
Brain & Behavior Research Foundation to award grants to 40 scientists for research into mental illness

Brain & Behavior Research Foundation to award grants to 40 scientists for research into mental illness

The Brain & Behavior Research Foundation today announced its 2015 Independent Investigator Grants which will award $3.9 million in funding to 40 mid-career scientists from 30 institutions in 16 countries. [More]
Hallucinations, delusions associated with psychiatric disorders seldom trigger violent crimes

Hallucinations, delusions associated with psychiatric disorders seldom trigger violent crimes

Mass shootings at the hands of unhinged loners - such as those in Aurora, Colorado; Santa Barbara, California, and Newtown, Connecticut - perpetuate a commonly held belief that mental illness triggers violent crimes. [More]
Study finds extremely high levels of cardiovascular risk factors in people with psychosis

Study finds extremely high levels of cardiovascular risk factors in people with psychosis

Extremely high levels of cardiovascular risk factors have been found in people with established psychosis, with central obesity evident in over 80 per cent of participants, in a study by researchers from the NIHR Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and King's College London. [More]
New study finds that some immigrants, refugees in Ontario at higher risk of psychotic disorders

New study finds that some immigrants, refugees in Ontario at higher risk of psychotic disorders

Immigrants from the Caribbean and Bermuda, as well as refugees from East Africa and South Asia, have a 1.5 to 2 times higher risk of psychotic disorders compared to the general population of Ontario, Canada, according to a new study by researchers at the Institute for Clinical Evaluative Sciences and the Centre for Addiction and Mental Health. [More]
New scanning methods could help predict people vulnerable to schizophrenia

New scanning methods could help predict people vulnerable to schizophrenia

New scanning methods which map the wiring of the brain could provide a valuable new tool to predict people at risk of schizophrenia, according to a new study. [More]
Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics, Inc. today announced business and financial results for the first quarter ended March 31, 2015. [More]
WHO and UNHCR jointly issue new guide to better identify, manage mental health needs

WHO and UNHCR jointly issue new guide to better identify, manage mental health needs

Worldwide close to 80 million people are currently impacted by humanitarian emergencies arising from natural disasters and armed conflicts, such as those in the Central African Republic, South Sudan, Syrian Arab Republic, Yemen, and more recently, Nepal. WHO estimates 5% to 10% of these people suffer from a mental health condition such as depression as a result of the emergency. [More]
Predominant first Alzheimer’s symptoms vary with diagnosis age

Predominant first Alzheimer’s symptoms vary with diagnosis age

The symptoms presented by patients newly diagnosed with Alzheimer’s disease vary with age, with younger patients less likely to have initial memory problems, research shows. [More]
Early neuropsychiatric symptoms prevalent in PD

Early neuropsychiatric symptoms prevalent in PD

Neuropsychiatric symptoms, but not cognitive impairment, are common in early untreated patients with Parkinson’s disease, suggest findings from the multicentre Parkinson’s Progression Markers Initiative. [More]
Advertisement